Dr. Tania Small

DR. TANIA SMALL is vice president oncology global medical at GSK, where she oversees all aspects of medical affairs for oncology. She joined GSK in 2018 from Ipsen Bioscience, where she was VP of oncology global drug development. She previously served as senior medical director for clinical development and medical affairs at Novartis. A board-certified pediatrician, Small is a pediatric hematology, oncology and bone marrow transplant specialist with deep experience in clinical research and drug development.  She has done research in oncology, hematology, gene therapy and stem cell transplantation, receiving NIH grants for her translational research in gene therapy and regenerative medicine. Not only has Small successfully led the launch programs of multiple oncology therapies, she has also led many patient-centered and diversity initiatives. She is passionate about revolutionizing the experience and outcomes for people with cancer and will continue driving innovative approaches to research and development until we get there. @gsk